Metropolis Partners Metropolis Partners

Metropolis Ventures, LLC

Metropolis Ventures has directly invested in or acted as manager to the investment vehicle that has invested in the following private early stage since May 2000.


Calypso Medical Technologies, Inc. is a medical device company dedicated to improving the delivery of targeted cancer therapies. Calypso’s commitment is to solve the problems associated with the organ motion during radiation treatment by developing technology that provides accurate, objective and continuous knowledge of the treatment site during radiation therapy. Early Stage Investment – Series B,C& D Financings.


Futuretrade provides a fully integrated electronic trading platform for institutional traders. The company's innovative platform helps institutional traders and hedge fund managers analyze, execute and manage positions in U.S. equities with speed and efficiency. Early Stage Investment – Series A,B,C & D Financings. Company sold to Interactive Brokers Group (IBKR) in Nov. 2007

Initiate Systems

Initiate Systems is a leading provider of customer-centric master data management and Enterprise Master Person Index (EMPI) software and services for the on-demand enterprises. Clients include IBM, Microsoft, and Choice Hotels. Early Stage investment – Series C&E Financing. Company sold to IBM in Feb 2010.


Early Stage Investment - Series B & C Financing. Company sold to Vivendi Universal in 2001


Pharmion is a global biotech company that is dedicated to the hematology and oncology communities. Pharmion works in partnership with a network of scientific and clinical advisors. Early stage Investment, Company has its completed IPO in November 2003.


Solazyme, Inc. is a renewable oil production company and the leader in algal synthetic biology. Solazyme’s unique microbial conversion technology process allows algae to produce oil in standard industrial facilities quickly, efficiently and at large scale. These oils are tailored not only for advanced biofuel production, but also as replacements for fossil petroleum and plant oils in a diverse range of products running from green household cleaning supplies to cosmetics and foods.

Spectrum Industrial

Spectrum Industrial is America's largest recycler of offset inks for commercial and newspaper printers. Production facilities in Minnesota and California provide high quality recycled ink. Spectrum Industrial has an extensive client list, including some of the largest commercial printers in the United States. Early Stage Investment - Series A Financing.


Syntonix is developing next generation biopharmaceuticals that enable better treatment options for patients with devastating chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. Early Stage Investment, Multiple Series – Company was purchased in Jan 2007 by Biogen Idec Inc. (BIIB)


Since its inception in 1996, Venetec International has rapidly emerged as the world leader in catheter securement technology. Nearly a dozen distinct, proprietary StatLock product families now establish the international standard in catheter securement. Early Stage Investment – Multiple Series. Venetec was purchased in October 2006 by C.R. Bard. (BCR)


Vintara is the leading provider of Web-based enterprise process management solutions and services. Vintara has a proven track record of helping the enterprise successfully prepare for and cost-effectively maintain compliance with a range of domestic and internationally recognized standards, including the ISO series, OHSAS standards, FDA regulations, Sarbanes-Oxley Act, GPRA/FISMA, Gramm-Leach-Billey Act, and many others. Early Stage Investment - Series A Financing.